Inaugural Lectures
Permanent URI for this collection
Inaugural Lectures (Chemical Engineering)
Browse
Browsing Inaugural Lectures by Title
Now showing 1 - 3 of 3
Results Per Page
Sort Options
- ItemOpen AccessCancer in our Society(Obafemi Awolowo University Press, 1983-11-15) Olusi, S.OIn Nigeria, cancer statistics like any other statistics may be rather nebulous. Just as there are no accurate statistical data on our population figure, there is very little or accurate information on the incidence of cancer in the Nigerian society. However, we know that cancer ranks behind the major causes of death: malnutrition, malaria, infections and infestations and accidents.
- ItemOpen AccessA Catalogue of Alternatives(Obafemi Awolowo University Press, 1979-06-12) Sanni, S.AThe effects of Chemical Engineering are less obvious but are just as all-pervasive and growing infiltration of the products of engineering and technology into every home, and to the fact that our lives are more and more conditioned by engineering and technology. This is particularly true of the so-called Less Developed Countries. Consequently, indiscriminate pursuit of advanced technologies by these countries without adequate attention to the human and environmental problems are giving rise to a number of social and psychological maladies, the gravities of which are evident in our craze for imported products.
- ItemOpen AccessThe Potentials of Biochemical Engineering in Industrial Development(Obafemi Awolowo University Press, 1998-08-11) Layokun, S. K.The exploitation of micro-organisms is at the heart of biochemical engineering practice. The new science of molecular biology has produced a remarkable outpouring of new ideas and powerful techniques. From this revolution has sprung, in particular, a new discipline, called genetic engineering which gives us the power to alter living organisms for important purposes in medicine, agriculture and industry. The resulting biotechniques span the range from the ancient art of fermentation principles (about 7,000 BC) to the new esoteric use of gene splicing and monoclonal antibodies.